Lava Therapeutics B.V. (NASDAQ:LVTX) Downgraded by Zacks Investment Research to Hold

Lava Therapeutics B.V.} stock has undergone multiple analysts rating changes in the recent past.  Lava Therapeutics B.V. Downgraded by Zacks Investment Research on 10/19/2021. In a note to investors, the firm issued a new rating of Hold. The analysts previously had rating of Buy.

View More Lava Therapeutics B.V. (NASDAQ:LVTX) Downgraded by Zacks Investment Research to Hold